INBX Operating Cash Flow (Statement)
Inhibrx Biosciences Inc · Operating Cash Flow (Statement)
INBX Operating Cash Flow (Statement)
Latest reported-$29.92Mperiod ending
INBX Quarterly Cash from Operations (-$7.01M → -$29.92M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
INBX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -29,917,000 | |
| -38,026,000 | |
| -30,122,000 | |
| -33,824,000 | |
| -29,953,000 | |
| -35,895,000 | |
| -43,720,000 | |
| -30,281,000 | |
| -57,358,000 | |
| -63,050,000 | |
| -56,821,000 | |
| -54,245,000 | |
| -42,299,000 | |
| -26,939,000 | |
| -30,600,000 | |
| -30,838,000 | |
| -26,922,000 | |
| -26,941,000 | |
| -22,620,000 | |
| -13,675,000 | |
| -22,380,000 | |
| -21,648,000 | |
| -15,389,000 | |
| -13,882,000 | |
| -11,309,000 | |
| -7,388,000 | |
| -11,942,000 | |
| -773,000 | |
| -13,787,000 | |
| -5,577,000 | |
| -6,924,000 | |
| -13,007,000 | |
| -2,114,000 | |
| -7,009,000 |